Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-24

FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Firmagon (degarelix) from Ferring Pharmaceuticals Inc., resulting in an updated label for the prostate cancer in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Firmagon (Degarelix)

Snippet

SUPPL AP for FIRMAGON (DEGARELIX)